REFERENCES
- Coupland SE, Chan CC, Smith J. Pathophysiology of retinal lymphoma. Ocul Immunol Inflamm. 2009;17:227–237.
- Faia LJ, Chan CC. Primary intraocular lymphoma. Arch Pathol Lab Med. 2009;133:1228–1232.
- Chan CC, Buggage RR, Nussenblatt RB. Intraocular lymphoma. Curr Opin Ophthalmol. 2002;13:411–418.
- Chan C-C. Molecular pathology of primary intraocular lymphoma. Trans Am Ophthalmol Soc. 2003;101:275–292.
- Cao X, Shen D, Callanan DG, et al. Diagnosis of systemic metastatic retinal lymphoma. Acta Ophthalmol. 2011;89:e149–e154.
- Salomão DR, Pulido JS, Johnston PB, et al. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma. JAMA Ophthalmol. 2013;131:1151–1158.
- Jahnke K, Korfel A, Komm J, et al. Intraocular lymphoma 2000–2005: results of a retrospective multicentre trial. Graefes Arch Clin Exp Ophthalmol. 2006;244:663–669.
- Wu X-C, Andrews P, Chen VW, et al. Incidence of extranodal non-Hodgkin lymphomas among whites, blacks, and Asians/Pacific Islanders in the United States: anatomic site and histology differences. Cancer Epidemiol. 2009;33:337–346.
- Ferreri AJM. Risk of CNS dissemination in extranodal lymphomas. Lancet Oncol. 2014;15:e159–e169.
- Yoshimura T, Sonoda K, Sugahara M, et al. Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PLoS One. 2009;4:e8158.
- Kimura K, Usui Y, Goto H, et al. Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma. Jpn J Ophthalmol. 2012;56:383–389.
- Matsuo T, Ichimura K. Immunocytochemical diagnosis as inflammation by vitrectomy cell blocks in patients with vitreous opacity. Ophthalmology. 2012;119:827–837.
- Usui Y, Wakabayashi Y, Okunuki Y, et al. Immune mediators in vitreous fluids from patients with vitreoretinal B-cell lymphoma. Investig Ophthalmol Vis Sci. 2012;53:5395–5402.
- Diss TC, Peng H, Wotherspoon AC, et al. Detection of monoclonality in low-grade B-cell lymphomas using the polymerase chain reaction is dependent on primer selection and lymphoma type. J Pathol. 1993;169:291–295.
- Gleissner B, Siehl J, Korfel A, et al. CSF evaluation in primary CNS lymphoma patients by PCR of the CDR III IgH genes. Neurology. 2002;58:390–396.
- Akpek EK, Ahmed I, Hochberg FH, et al. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes. Ophthalmology. 1999;106:1805–1810.
- Sagoo MS, Mehta H, Swampillai AJ, et al. Primary intraocular lymphoma. Surv Ophthalmol. 59: 503–516.
- Wallace DJ, Altemare CR, Shen DF, et al. Primary testicular and intraocular lymphomas: two case reports and a review of the literature. Surv Ophthalmol. 2006;51:41–50.
- Ahmad SS, Idris SF, Follows GA, et al. Primary testicular lymphoma. Clin Oncol (R Coll Radiol). 2012;24:358–365.
- Streilein JW. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol. 2003;3:879–889.
- Aliferis K, Chan CC, Donati G, et al. Intraocular lymphoma following a primary testicular lymphoma in remission for 10 years. Int Ophthalmol. 2008;28:439–440.
- Davis JW, Moriarty RP, Schlossberg SM, et al. Bilateral testicular lymphoma treated with chemotherapy and radiation without orchiectomy: complete response relapsed at 52 months in the vitreous humor. Urology. 2001;57:555.
- Pe’er J, Rowe JM, Frenkel S, et al. Testicular lymphoma, intraocular (vitreoretinal) lymphoma, and brain lymphoma: involvement of three immunoprivileged sites in one patient. Am J Hematol. 2010;85:631–633.
- Grange LK, Jacobs-El N, Wiley HE, et al. Intraocular (vitreoretinal) lymphoma following primary testicular lymphoma. Can J Ophthalmol. 2013;48:e95–e97.
- Tomita N, Yokoyama M, Yamamoto W, et al. Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era. Cancer Sci. 2012;103:245–251.
- Hosein PJ, Maragulia JC, Salzberg MP, et al. A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era. Br J Haematol. 2014;165:358–363.